Objectives: We examined whether measurement of the plasma BNP concentrations might be useful for the early diagnosis of the existence and severity of disease in patients with heart disease in daily clinical practice. Methods and Results: The plasma BNP and ANP concentrations in 415 patients with heart disease and hypertension and 65 control subjects were measured. Patients with heart disease had higher plasma BNP and ANP concentrations than did those with hypertension or control subjects. Among the etiology of cardiac diseases, specifically dilated cardiomyopathy and hypertrophic cardiomyopathy, was associated with the highest plasma BNP concentrations, whereas dilated cardiomyopathy was associated with the highest plasma ANP concentrations. Plasma BNP concentrations showed an increase as the severity of the heart disease, as graded according to the NYHA classification of cardiac function, increased. In both patients with heart disease and hypertension, the plasma BNP values were higher in those who had abnormalities in their echocardiogram and electrocardiogram as compared to those without any abnormalities. The plasma BNP levels also showed a significant correlation with left ventricular wall thickness and left ventricular mass. On the other hand, the plasma ANP levels showed significant correlations with left ventricular dimension. Receiver operative characteristic analysis revealed that plasma BNP levels showed substantially high sensitivity and specificity to detect the existence of heart diseases. Conclusion: Measurements of the plasma BNP concentrations is useful to detect the existence of the diseases, and abnormalities of left ventricular function and hypertrophy in patients with heart disease in daily clinical practice.
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1. Introduction failure [3] , while being poorly specific for the causal disease. ANP is primarily produced by myocardial cells in Brain natriuretic peptide (BNP), a hormone consisting the atrium, whereas BNP is primarily secreted in the of 32 amino acids, was isolated / identified from the brains ventricles [4] ; BNP may thus be a specific index reflecting of pigs in 1988 [1] . Despite the BNP gene and atrial the early stage of heart disease or impaired cardiac natriuretic peptide (ANP) gene being located adjacent to function. In fact, it is known that the plasma BNP each other [2] , their secretory kinetics are often dissoconcentrations are significantly higher than those of ANP ciated. ANP secretion is stimulated by atrial dilatation.
in various heart diseases, particularly severe heart failure Plasma ANP levels therefore reflect the severity of heart [5] , hypertrophic cardiomyopathy [6] and acute myocardial infarction [7] . These findings have, however, been reported from controlled studies focusing on hospitalized patients, from cardiovascular diseases were included. They had no that is, studies in which the morbidity status of the patients symptoms, and no evidence of significant disease was was well defined.
detected by physical examination, chest radiography, restPresently, it is often difficult to diagnose patients with ing and exercise electrocardiography, or routine laboratory mildly symptomatic heart disease or impaired cardiac tests. function. In particular, patients with hypertension may
We excluded patients with other cardiac diseases. Exdevelop progressive cardiovascular complications without cluded from the study were patients with aneurysms, heart showing any symptoms. Cowie et al. [8] have shown that failure in the NYHA classes III and IV, metabolic diseases, plasma BNP is a useful diagnostic tool for patients with such as hyperthyroidism, severe lung diseases, renal failure heart failure in primary care. We thus examined whether and liver failure. We also excluded those who had an measurement of the plasma BNP concentrations during implanted pacemaker and hospitalized patients. routine consultations would reflect the morbidity status of
The diagnostic criteria for hypertension was a blood the patients. Namely, we attempted to identify patient pressure of 140 and / or 90 mmHg or higher or a history of background factors that may affect the plasma BNP treatment with antihypertensive agents. Patients with left concentrations in patients with cardiovascular diseases, and ventricular dilatation but normal coronary arteries and a investigated whether determination of the plasma BNP thin left ventricular wall without a known cardiac disease, concentrations might be useful for the early detection of such as hypertensive heart disease or hypertrophic carheart diseases and understanding the morbidity status of diomyopathy, were diagnosed as having idiopathic dilated such diseases, in comparison with that of the plasma ANP cardiomyopathy. Hypertrophic cardiomyopathy was diagconcentrations.
nosed mainly by echocardiography: presence of systolic anterior movement of the mitral valve and asymmetric ventricular hypertrophy; the interventricular septum was at least 1.3 times as thick as the posterior wall. They did not 2. Methods present other causes of ventricular hypertrophy, such as hypertension and aortic stenosis.
Subjects
The study was conducted on a total of 480 patients with 2.2. Protocols cardiovascular diseases including hypertension and control subjects, who visited the six participating institutions from
We examined the correlation between the plasma BNP February 1998 to October 1999. This study conforms with levels and the patient background factors. Furthermore, we the principles outlined in the Declaration of Helsinki. Each divided the patients into a normal group and an abnormal of the patients gave his / her informed consent for participagroup based on the electrocardiographic findings and tion in the study.
echocardiographic findings, and compared the mean plasThe underlying disease was diagnosed through a routine ma ANP and BNP concentrations between the two groups. consultation, physical examinations and clinical laboratory Echocardiographic parameters were measured within 1 tests. Chest radiography, electrocardiography at rest, echmonth from the plasma BNP and ANP measurement. Left ocardiography, and measurements of the plasma BNP and ventricular dimension was measured in a long axis view of ANP concentrations were performed. In patients undergothe left ventricle taken with the patient in the left lateral ing treatment, the drug administration schedules were position. Left ventricular volume was obtained using maintained.
Teichholz's equation: left ventricular volume5(7.0 / 2.41 3 We examined 154 patients with heart diseases, 261 dimension)3dimension . hypertensive patients, and 65 control subjects. The underLeft ventricular ejection fraction (LVEF) was obtained lying heart diseases included old myocardial infarction in by the following formulae: LVEF5(LV end-diastolic 28 patients, angina pectoris in 46 patients, idiopathic volume2end-systolic volume) / LV end-diastolic volume. dilated cardiomyopathy in 26 patients, hypertrophic carLeft ventricular mass (LVM) was calculated by the method diomyopathy in 18 patients, valvular heart diseases in 24 of Devereux et al. [9] . patients, and lone atrial fibrillation in 12 patients. AccordPatients with ejection fraction (EF) ,60%, diastolic ing to the New York Heart Association (NYHA) functional dimension (Dd) .55 mm, systolic dimension (Ds) .42 classification, 110 patients were in class I and 44 in class mm, interventricular septum thickness (IVSTD) .12 mm, II. There were 15 patients with mitral valve disease, four posterior wall thickness (PWTD) .12 mm, and left with aortic valve disease, one with tricuspid valve disease ventricular fractional shortening (FS) of less than 29% and four with combined valvular disease. Control subjects were identified and grouped into an abnormal group, and who came to the hospitals for health check or some other the BNP and ANP levels between the normal and abnorcomplaints, but were eventually diagnosed as being free mal groups were compared.
Measurement of plasma BNP concentration
plasma BNP and ANP concentrations might be useful in detecting the existence of heart diseases using receiver Blood samples were collected from the patients in the operating characteristic (ROC) analysis. The sensitivity sitting position in syringes containing EDTA (1 mg / ml) and specificity of determination of the plasma BNP and aprotinin (103 KIU / ml). Serum was separated within concentrations were calculated, and an ROC curve was 6 h and the samples were stored frozen at 2208C until the drawn. The sensitivity was defined as the percentage of measurements. The concentrations of BNP and ANP were patients who showed higher BNP and ANP values than a measured within 1 week after plasma sampling by an certain concentration among the total number of patients immunoradiometric assay (IRMA) method described bewith heart disease and controls. On the other hand, the fore [10] . specificity was defined as the percentage of patients showing lower BNP levels than a certain concentration 2.4. Statistical analysis among the total number of patients with heart disease and controls. Differences between areas under ROC curves for For comparison of the mean values, when significant ANP and BNP were compared with a studentized range difference was noted by analysis of variance, Welch's test test [11] . was performed for analyzing the differences between two groups. Since distribution of ANP and BNP showed unequal variances, nonparametric Tukey type multiple 3. Results comparison was used for analyzing the differences among multiple groups. All of the tests were two-tailed, with the 3.1. Distribution of plasma BNP and ANP level of significance set at 0.05.
concentrations according to patient background factors The correlations between the plasma BNP or ANP levels and the NYHA class, echocardiographic findings, electroPatients with heart disease had higher plasma BNP and cardiographic results, systolic blood pressure (SBP), dias-ANP concentrations than did those with hypertension or tolic blood pressure (DBP), and pulse rate were analyzed control subjects (Fig. 1) . Among the etiology of cardiac by the least square method. Multiple regression analyses diseases, specifically hypertrophic cardiomyopathy, was on BNP and ANP were performed with the use of all the associated with the highest plasma BNP concentrations, variables. 'Disease' was classified into three levels, i.e.
whereas dilated cardiomyopathy was associated with the control, hypertension and heart disease.
highest plasma ANP concentrations. We also examined to what extent measurement of the Plasma BNP and ANP concentrations showed an in- † ¶ Fig. 1 . Distribution of plasma BNP concentrations and ANP concentrations by the underlying disease. *P,0.05, P,0.01, P,0.001, vs. control.
crease as the severity of the heart disease according to the NYHA functional classification increased. Moreover, the plasma BNP values, but not ANP values, were higher even in patients with NYHA class I than in control subjects (Fig. 2) . Although the plasma ANP levels also increased with the severity of the heart disease in the same manner as the plasma BNP levels, the extent of elevation was larger in the case of the plasma BNP levels.
Correlation of plasma BNP and ANP levels with the cardiac findings and laboratory test values
Significantly higher BNP values were noted in the group of patients with abnormal electrocardiographic findings, such as atrial fibrillation, left ventricular high voltage, ST changes, and T wave change. Plasma ANP levels were also Higher BNP values were found in all the patients in the abnormal EF, Ds, IVTD, PWTD, and FS group, and the (P,0.001) and atrial fibrillation (P,0.01) were significant differences between the normal and abnormal groups were determinants of ANP. significant (Fig. 4) . Plasma ANP levels also showed a
In patients with hypertension also, the plasma BNP tendency towards being higher in the abnormal group, levels showed a negative correlation with the EF and however no significant differences in EF, IVSTD, PWTD, positive correlation with the Ds, IVSTD, PWTD, LVM, FS were noted between those with abnormal and those DBP, and pulse rate, while plasma ANP levels showed a with normal echocardiographic findings. Similar results positive correlation with only SBP and DBP. were obtained in the group of patients with hypertension.
As indicated in Table 1 , the plasma BNP levels as a 3.3. Sensitivity and specificity of plasma BNP levels to whole showed a negative correlation with the EF and detect the existence of heart diseases positive correlation with the Ds, IVSTD, PWTD, and LVM (r50.34, P,0.0001, Fig. 5 ). On the other hand, the plasma In order to assess the usefulness of measurement of the ANP levels showed a negative correlation with the EF and plasma BNP and ANP levels for the purposes of diagnosis, positive correlation with the Dd, Ds, PWTD and LVM. Correlations of BNP with age (P,0.05), disease (P,0.02), left ventricular mass (P,0.0001) and atrial fibrillation (P,0.0001) were statistically significant by multiple regression analysis. Age (P,0.0001), left ventricular mass studies, the plasma BNP concentrations in patients with heart disease were elevated in this study also. The present SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate.
study is thus consistent with findings that measurement of the plasma BNP levels may be useful for the screening of the areas under the ROC curves (AUC) were calculated. latent heart diseases [12] . As a result, the AUC of BNP tended to be greater than that It is well known that the blood ANP concentrations are of ANP (AUC6variance; BNP 0.86460.00058 vs. ANP elevated in atrial fibrillation, particularly in paroxysmal 0.78760.00118, P50.0655) (Fig. 6 ). This suggests that atrial fibrillation, and researchers have suggested this may both the sensitivity and specificity of BNP determination be one of the factors causing tachycardia-induced polyuria were superior for detecting the morbidity status in patients [13, 14] . In our study also, patients with atrial fibrillation with heart disease. Using cut-off values of 15 pg / ml, BNP showed high plasma BNP values. The mechanism by determination showed a sensitivity of 73.9% and spewhich atrial fibrillation strongly induces the secretion of cificity of 83.1% in patients with heart disease. Those of the primarily ventricle-derived BNP is unknown. However, may be derived from the atrial tissue. Since atrial fibrillation is one of the significant risk factors of embolism, elevated BNP values could be considered as a warning signal in relevant cases. In this study, the BNP levels were measured in patients most of whom were taking various drugs. Therefore, the effects of the drugs have undeniably contributed to the results. However, we believe that altered plasma natriuretic peptide concentrations in patients taking drugs for cardiovascular diseases are often more reflective of the altered cardiac function under medication. For example, angiotensin converting enzyme (ACE) inhibitors are known to reduce plasma BNP concentrations in patients with cardiac failure [17] and those with hypertension [18] . However, these may not be because of the direct actions of ACE inhibitors on BNP secretion, but due to reduction of the cardiac afterload and reduction of cardiac hypertrophy effected by them. On the other hand, b-blockers have been reported to elevate the plasma concentrations of ANP and BNP [19, 20] . These studies have suggested that this effect of elevating plasma natriuretic peptide concentrations may partially contribute to the overall effects of b-blockers [21] . Our study did not show any clear differences in plasma ANP or BNP concentrations between patients administered b-blockers and those administered other drugs (data not shown). Therefore, the plasma BNP concentrations measured in the study were probably influenced little by the drugs administered, and for the most part, may be reflective of the underlying cardiac overload.
Plasma BNP concentrations have been suggested to be a useful index to determine the prognosis in cases of myocardial infarction [22] and cardiac failure [23] . Plasma norepinephrine concentrations, used also as an index of prognosis in cases of cardiac failure [24] are markedly altered by many factors. Furthermore, the volume of salt intake or the physical position of the patient during the activity. Plasma BNP concentrations are not subject to these influences, and this may be of advantage for the use since the levels were increased not only in patients of atrial of plasma BNP concentrations as an index of the severity fibrillation with underlying heart disease, such as valvular of cardiac disease in daily practice. heart disease, but also in those with lone atrial fibrillation, The plasma BNP concentrations have shown correlation a BNP secretion-inducing mechanism may be present.
with the measurements of left ventricular hypertrophy, Inoue et al. [15] reported that the plasma BNP levels in namely IVSTD, PWTD, and LVM. Studies have reported patients with lone atrial fibrillation were significantly that the prognosis of patients with essential hypertension higher than those in controls. They also found higher BNP complicated by cardiac hypertrophy is poor, and that the levels in the coronary sinus than in the anterior interincidence rate of cardiac accidents in these patients is high ventricular vein, suggesting an increase in atrium-derived
[25]. Bettencourt et al.
[26] found a significant relationship BNP. Furthermore, Tuinenburg et al. [16] reported about between BNP and left ventricular mass in community mild 70% higher pro-BNP mRNA levels in the right atrial to moderate hypertensive patients. Higher BNP levels have appendage in patients with atrial fibrillation as compared been reported to be found in cases with concentric with those in subjects with sinus rhythm. Increased levels hypertrophy as compared with those with eccentric hywere noted in these cases regardless of the existence of pertrophy [27] , therefore, the plasma BNP concentration underlying valvular disease. These findings suggest that may be an excellent clinical index for determining the risk the increased BNP levels in patients with atrial fibrillation of cardiac events and the prognosis of the patients. Thus, 
